Liposomes as immunological adjuvants and vaccine carriers

Journal of Controlled Release

Volumn 41, Issue 1-2, 1996, Pages 49-56

  Gregoriadis, Gregory ^a   Gursel, Ihsan ^a   Gursel, Mayda ^a   McCormack, Brenda ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Antigens; Immune response; Immunological adjuvant; Interleukins; Liposomes; Vaccines

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BACTERIAL ANTIGEN; CHOLESTEROL; CYTOKINE; DISTEAROYLPHOSPHATIDYLCHOLINE; DRUG CARRIER; EPITOPE; IMMUNOLOGICAL ADJUVANT; LIPOSOME; PHOSPHATIDYLCHOLINE; PRASTERONE; TUMOR ANTIGEN; VACCINE; VIRUS ANTIGEN;

ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CELLULAR IMMUNITY; CONFERENCE PAPER; DRUG TARGETING; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOPOTENTIATION; MACROPHAGE; METHODOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTOZOON; T LYMPHOCYTE;

EID: 0030222367     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-3659(96)01355-7     Document Type: Conference Paper

References (65)

1. [1] G. Gregoriadis, A.C. Allison and G. Poste, (Eds.), Immunological Adjuvants and Vaccines, Plenum, New York, 1989.
2. [2] G. Gregoriadis, Liposomes as immunological adjuvants, in: D.E.S. Stewart-Tull (Ed.), The Theory and Application of Adjuvants, John Wiley, Chichester, 1994, pp. 145-169.
3. [3] G. Gregoriadis, A.C. Allison and G. Poste (Eds.), Vaccines: Recent Trends and Progress, Plenum, New York, 1991.
4. [4] G. Gregoriadis, B. McCormack, A.C. Allison and G. Poste (Eds.), New Generation Vaccines: The Role of Basic Immunology, Plenum, New York, 1993.
5. [5] G. Gregoriadis, (Ed.), Liposomes as Drug Carriers: Recent Trends and Progress, John Wiley, Chichester, 1988.
6. [6] G. Gregoriadis, Immunological adjuvants: a role for liposomes, Immunol. Today 11 (1990) 89-97.
7. [7] G. Gregoriadis, (Ed.), Liposome Technology, 2nd edition, CRC Press Inc., Boca Raton, FL, 1993.
8. [8] G. Gregoriadis and A.T. Florence, Liposomes in drug delivery: clinical, diagnostic and ophthalmic potential, Drugs 45 (1993) 15-28.
9. [9] D. Lasic and F. Martin (Eds.), Stealth Liposomes, CRC Press, Boca Raton, FL, 1995.
10. [10] F. Puissieux, P. Couvreur, J. Delattre and J.-P. Devissanet (Eds.), Liposomes, New Systems and New Trends in their Applications, Editions de Santé, Paris, 1995.
11. [11] G. Gregoriadis, Engineering liposomes for targeted drug delivery, Trends Biotechnol. 13 (1995) 527-537.
12. [12] C. Kirby and G. Gregoriadis, Dehydration-rehydration vesicles (DRV): a new method for high yield drug entrapment in liposomes, Biotechnology 2 (1984) 979-984.
13. [13] G. Gregoriadis, R. Saffie and S. Hart, High yield incorporation of plasmid DNA within liposomes: effect on DNA integrity and transfection efficiency, J. Drug Targeting (1996) in press.
14. [14] G. Gregoriadis, Liposomes in Drug Targeting, in: J.E. Cellis (Ed.), Cell Biology: A Laboratory Handbook, Academic Press, Orlando, 1994, pp. 58-66.
15. [15] G. Gregoriadis, N. Garçon, H. da Silva and B. Sternberg, Coupling of ligands to liposomes independently of solute entrapment: observations on the formed vesicles. Biochim. Biophys. Acta 1147 (1993) 185-193.
16. [16] B. McCormack and G. Gregoriadis, Drugs-in-cyclodextrinsin liposomes: A novel concept in drug delivery, Int. J. Pharm. 112 (1994) 249-258.
17. [17] G. Gregoriadis, D. Davis and A. Davies, Liposomes as immunological adjuvants: antigen incorporation studies, Vaccine 5 (1987) 143-149.
18. [18] G. Gregoriadis, H. da Silva and A.T. Florence, A procedure for the efficient entrapment of drugs in dehydration-rehydration liposomes (DRV), Int. J. Pharm. 65 (1990) 235-242.
19. [19] S. Antimisiaris, P. Jayasekera and G. Gregoriadis, Liposomes as vaccines carriers: incorporation of soluble and particulate antigens in giant vesicles, J. Immunol. Methods 166 (1993) 271-280.
20. [20] I. Gursel, P. Jayasekera and G. Gregoriadis, Giant liposomes as potential vehicles for live or attenuated microbial vaccines, in: P. Shek, (Ed.), Liposomes in Biomedical Applications, Harwood Academic Publishers, Chur, 1995, pp. 35-50.
21. [21] A.C. Allison and G. Gregoriadis, Liposomes as immunological adjuvants, Nature 252 (1974) 252.
22. [22] C.R. Alving, Liposomes as carriers of antigens and adjuvants, J. Immunol. Methods 140 (1991) 1-13.
23. [23] P.N. Shek, Immunotoxicology, Mullen, P.W. (Ed.), Springer-Verlag, Berlin, 1984, pp. 103-125.
24. [24] H.-M. Therien and E. Shahum, Importance of physical association between antigens and liposomes in liposomal adjuvanticity, Immunol. Lett. 22 (1989) 253-258.
25. [25] D. Davis, A. Davies and G. Gregoriadis, Liposomes as adjuvants with immunopurified tetanus toxoid: the immune response, Immunol. Lett. 14 (1987) 341-348.
26. [26] N.C. Phillips and A. Emili, Enhanced antibody response to liposome-associated protein antigens: preferential stimulation of IgG2a/b production, Vaccine 10 (1992) 151-158.
27. [27] M. Velinova, N. Read, C. Kirby and G. Gregoriadis, Morphological observations on the fate of liposomes in the regional lymphs nodes after footpad injection into rats, Biochim. Biophys. Acta 1299 (1996) 207-215.
28. [28] J.D. Beatty, B.G. Beatty, F. Paraskevas and E. Froese, Liposomes as immunological adjuvants: T cell dependence, Surgery 96 (1984) 345-351.
29. [29] D. Su and R. van Nieuwmegan, The role of macrophages in the immunoadjuvant action of liposomes: effects of elimination of splenic macrophages on the immune response against intravenously injected liposome-associated albumin antigen, Immunology 66 (1989) 466-470.
30. [30] E.K. Manesis, C.H. Cameron and G. Gregoriadis, Hepatitis B surface antigen-containing liposomes enhance humoural and cell-mediated immunity to the antigen, Fed. Eur. Biochem. Soc. Lett. 102 (1979) 107-111.
31. [31] G. Gregoriadis, Z. Wang, Y. Barenholz and MJ. Francis, Liposome-entrapped T-cell peptide provides help for a coentrapped B-cell peptide to overcome genetic restriction in mice and induce immunological memory, Immunology 80 (1993) 535-540.
32. [32] L.M. Lopes and B.M. Chain, Liposome-mediated delivery stimulates a class I restricted cytotoxic T cell response to soluble antigen, Eur. J. Immunol. 22 (1992) 287-290.
33. [33] R. Reddy, F. Zhou, S. Nair, L. Huang and B.T. Rouse, In vivo cytotoxic T lymphocyte induction with soluble proteins administered in liposomes, J. Immunol. 148 (1992) 1585-1589.
34. [34] M.O. Dailey and R.L. Hunter, Induction of cell-mediated immunity to chemically-modified antigens in guinea pigs. 1. Lipid-conjugated protein antigens, J. Immunol. 118 (1977) 957-962.
35. 111In-labelled bleomycin after subcutaneous injection into rats, Biochim. Biophys. Acta 760 (1983) 119-125.
36. [36] C.V. Harding, D.S. Collins, J.W. Slot, H.J. Geuze and E.R. Unanue, Liposome-encapsulated antigens are processed in liposomes, recycled and presented to T cells. Cell 64 (1991) 393-401.
37. [37] Gregoriadis, G. Liposomes as immunological adjuvants: approaches to immuno-potentiation including ligand-mediated targeting to macrophages, Res. Immunol. 143 (1992) 178-185, 245-246.
38. [38] P. Dal Monte and F.C. Szoka, Effects of liposome encapsulation on antigen presentation in vitro. Comparison of presentation by peritoneal macrophages and B cell tumours, J. Immunol. 142 (1989) 1437-1443.
39. [39] S. Nair, F. Zhou, R. Reddy, L. Huang and B.T. Rouse, Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte response in vitro, J. Exp. Med. 175 (1992) 609-612.
40. [40] N. Garçon, G. Gregoriadis, M. Taylor and J. Summerfield, Targeted immunoadjuvant action of tetanus toxoid-containing liposomes coated with mannosylated albumin, Immunology 64 (1988) 743-745.
41. [41] D. Davis and G. Gregoriadis, Liposomes as adjuvants with immunopurified tetanus toxoid: Influence of liposomal characteristics, Immunology 61 (1987) 229-234.
42. [42] L. Tan and G. Gregoriadis, The effect of interleukin-2 on the immunoadjuvant action of liposomes, Biochem. Soc. Trans. 17 (1989) 693-694.
43. [43] M. Gürsel and G. Gregoriadis, Immunoadjuvant action of liposomes containing interleukin-2 as a co-adjuvant, Proc. Intern. Symp. Control. Rel. Bioact. Mater. 22 (1995) 438-439.
44. [44] E. Abraham and S. Shah, Intranasal immunization with liposomes containing IL-2 enhances bacterial polysaccharide antigen-specific pulmonary secretory antibody response, J. Immunol. 149 (1991) 3719-3725.
45. [45] I.N. Mbawiuke, P.R. Wyde and P.M. Anderson, Enhancement of the protective efficacy of inactivated influenza A virus vaccine in aged mice by IL-2 liposomes, Vaccine 8 (1990) 347-352.
46. [46] M. Cao, O. Sasaki, A. Yamada and J. Imanishi, Enhancement of the protective effect of inactivated influenza virus vaccine by cytokines, Vaccine 10 (1992) 238-242.
47. [47] R.J.Y. Ho, R.L. Burke and T.C. Merigan, Liposome-formulated interleukin-2 as an adjuvant of recombinant HSV glycoprotein gD for the treatment of recurrent genital HSV-2 in guinea-pigs, Vaccine 10 (1992) 209-213.
48. [48] F. Garnier, F. Forquet, P. Bertolino and D. Gerlier, Enhancement of in vivo and in vitro T cell response against measles virus haemagglutinin after its incorporation into liposomes: effect of the phospholipid composition, Vaccine 9 (1991) 340-345.
49. [49] S.C. Kinsky, Immunogenicity of liposomal model membranes, Ann. N.Y. Acad. Sci. 308 (1978) 111-123.
50. [50] M.J. Francis, C.M. Fry, D.J. Rowlands, F. Brown, J.L. Bittle, R.A. Houghten and R.A. Lerner, Immunological priming with synthetic peptides of foot-and-mouth disease virus, J. Gen. Virol. 66 (1985) 2347-2354.
51. [51] C.A. Kraaijeveld, M. Schilham, J. Jansen, B. BenaissaTrouw, M. Harmsen, A.J. van Houte and H. Snippe, The effect of liposomal charge on the neutralizing antibody response against inactivated encephalomyocarditis and Semliki Forest viruses, Clin. Exp. Immunol. 56 (1984) 509-514.
52. [52] E. Shahum and H.M. Therien, Immunopotentiation of the humoral response by liposomes: encapsulation versus covalent linkage, Immunology 65 (1988) 315-317.
53. [53] N. Van Rooijen, Liposomes as immunological adjuvants: recent developments, in: G. Gregoriadis (Ed.), Liposomes as Drug Carriers: Recent Trends and Progress, Wiley, Chichester, 1988, pp. 145-165.
54. [54] M.J. Francis, Carriers for peptides: theories and technology. In: G. Gregoriadis, B. McCormack and G. Poste (Eds.), New Generation Vaccines: The Role of Basic Immunology, Plenum Press, New York, 1993, pp. 33-42.
55. [55] G. Goodman-Snitboff, L.E. Eisele, E.P. Heimer, A.M. Felix, T.T. Anderson, T.R. Fiuerst and R.J. Mannino, Defining minimal requirements for antibody production to peptide antigen, Vaccine 8 (1990) 257-262.
56. [56] M.H.V. Van Regenmortel, J.P. Briand, S. Muller and S. Plave, Synthetic polypeptides as antigens, in: R.H. Burdon and P.H. von Knippenberg (Eds.), Laboratory Techniques in Biochemistry and Molecular Biology, Elsevier, Amsterdam, 1988.
57. [57] J.L. Bittle, R.A. Houghten, H. Alexander, T.M. Schinnick, J.G. Sutcliff, R.A. Lerner, D.J. Rowlands and F. Brown, Protection against foot-and-mouth disease by immunization with a chemically synthesised peptide predicted from the viral nucleotide sequence, Nature 298 (1982) 30-33.
58. [58] L. Chedid, F. Audibert, M. Jolivet, C. Corelli, M. Uzan, H. Grasmasse and A. Tutar, Epitope specific immunity elicited by totally synthetic monovalent or polyvalent vaccines, Ann. Sclavo, 2 (1984) 77-86.
59. [59] M.F. Good, W.F. Maloy, M.N. Lunde, H. Margalit, J.L. Cornette, G.L. Smith, B. Moss, L.H. Miller and J.A. Berzofsky, Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein, Science 235 (1987) 1059-1062.
60. [60] F. Borras-Cuesta, A. Petit-Camurdan and Y. Fedon, Engineering of immunogenic peptides by co-linear synthesis of determinants recognised by B and T cells, Eur. J. Immunol. 17 (1987) 1213-1215.
61. [61] C.D. Partidos, O.E. Obeid and M.W. Steward, Antibody response to non-immunogenic synthetic peptides induced by co-immunization with immunogenic peptides, Immunology 77 (1992) 262-266.
62. [62] D.R. Milich, A. McLachlan, A. Moriarty and G.B. Thornton, A single 10-residue pre-S(1) peptide can prime T cell help for antibody production to multiple epitopes within the pre-S(1), pre-S(2) and S regions of HBsAg, J. Immunol. 138 (1987) 4457-4465.
63. [63] C.A. Minims, J.H.L. Playfair, I.M. Roitt, D. Wakelin and R. Williams, Medical Microbiology, Mosby, St. Louis, MO, 1993, Chapter 36.
64. [64] G. Gregoriadis and A.C. Allison, Entrapment of proteins in liposomes prevents allergic reactions in pre-immunized mice, Fed. Eur. Biochem. Soc. Lett. 45 (1974) 71-74.
65. [65] R. Glück, Combined vaccines - The European Contribution, Biologicals 22 (1994) 347-351.